✨ Medicines Distribution Consents




NEW ZEALAND GAZETTE

24 JUNE

1717

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Ascorbic acid 278 mg, sodium ascorbate 272 mg Tablet Nutrilite Products Inc., Buena Park, California, United States of America Nutriway C-500

Dated this 15th day of June 1993.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

gs95267

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Aluminium sulphate 20% w/v Gel Hamilton Laboratories Pty Ltd., Adelaide, South Australia Stingose
Ranitidine hydrochloride 150 mg Tablets Genpharm Inc., Etobicoke, Ontario, Canada Zantidin
Haemophilus influenzae type b conjugate vaccine containing 10 ug Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid protein in 0.5 ml Solution for IM injection Pasteur Merieux Serums et Vaccins, Marcy L'Etoile, France Act-HIB
Dobutamine hydrochloride 250 mg/20 ml Powder for injection David Bull Laboratories Pty Ltd., Mulgrave North, Victoria, Australia Dobutamine Hydrochloride Injection
Frusemide 10 mg/ml Solution for injection Astra Pharmaceuticals Pty Ltd., North Ryde, New South Wales, Australia Frusemide injection
Iotrolan 0.406 g/ml Solution for injection Schering Aktiengesellschaft, Berlin, Germany Isovist 190
Iotrolan 0.513 g/ml Solution for injection Schering Aktiengesellschaft, Berlin, Germany Isovist 240
Iotrolan 0.641 g/ml Solution for injection Schering Aktiengesellschaft, Berlin, Germany Isovist 300

Dated this 22nd day of June 1993.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.

gs95268

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Zidovudine 50 mg/5 ml Oral solution Wellcome Foundation Ltd., Dartford, Kent, England Retrovir
Captopril 12.5 mg, 25 mg, 50 mg Tablets E R Squibb & Sons Ltd., Wirral, Merseyside, England Capoten
Captopril 5 mg/ml Oral solution E R Squibb & Sons Ltd., Wirral, Merseyside, England Capoten
Buserelin 1.0 mg/ml Nasal spray Hoechst AG, Frankfurt am Main, Germany Suprefact
Ranitidine hydrochloride 150 mg/5 ml Syrup Glaxo Operations UK Ltd., Speke, Liverpool, England; Glaxo Operations UK Ltd., Ware, Hertfordshire, England; or Glaxo Operations UK Ltd., Barnard Castle, County Durham, England Zantac
Ranitidine hydrochloride 150 mg, 300 mg Capsules Banner Gelatin Products (Canada) Ltd., Olds, Alberta, Canada, or Banner Gelatin Products Corporation, Chatsworth, California, United States of America Zantac-C
Ranitidine hydrochloride 150 mg, 300 mg Tablets Glaxo Operations UK Ltd., Ware, Hertfordshire, England; Glaxo Operations UK Ltd., Barnard Castle, County Durham, England; Glaxo Manufacturing Services (NZ) Ltd., Palmerston North, or Glaxo Australia Pty Ltd., Boronia, Victoria, Australia Zantac


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1993, No 92


NZLII PDF NZ Gazette 1993, No 92





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of a New Related Product

πŸ₯ Health & Social Welfare
15 June 1993
Medicines Act 1981, New Related Product, Distribution
  • C. Lovelace, Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
22 June 1993
Medicines Act 1981, New Medicines, Distribution
  • C. Lovelace, Director-General of Health

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
22 June 1993
Medicines Act 1981, Changed Medicines, Distribution
  • C. Lovelace, Director-General of Health